Pre-diagnostic 25-hydroxyvitamin D concentrations in relation to tumor molecular alterations and risk of breast cancer recurrence | Heng Lab

Peng C, Heng Y, Lu D, DuPre N, Kensler K, Glass K, Zeleznik OA, Kraft P, Feldman D, Hankinson S, et al. Pre-diagnostic 25-hydroxyvitamin D concentrations in relation to tumor molecular alterations and risk of breast cancer recurrence. Cancer Epidemiol Biomarkers Prev. 2020;29(6):1253–1263.

Last updated on 03/07/2023